Friends, IDRA (Idera Pharma) just added another former Genzyme exec to the team . . . that makes three, including the Board chair. IDRA trading in the $4.35 range . . . working on new platform for autoimmune diseases (psoriasis in trial) . . . large institutional support in the past few months. I smell another ACAD here . . . maybe more. Happy investing.
Still like MACK too.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links